Innova Captab Q1 FY27 Results (NSE: INNOVACAP)

23 Aug 2026 · Analysis by Alpha Inflection

Signal: Growth decelerated

The read

The key trajectory remains elevated growth rather than margin expansion: consolidated revenue rose 33.9% YoY to ₹470.85 Cr and PAT rose 42.3% to ₹44.13 Cr, but EBITDA growth of 32.8% broadly matched revenue growth and held margin at 16%; the stronger standalone performance of 39.5% revenue and 57.9% PAT growth is the main positive inflection within the group.

P&L walk

Consolidated revenue grew 33.9% YoY to ₹470.85 Cr and EBITDA grew 32.8% to ₹75.13 Cr, keeping EBITDA margin at 16%; EBIT rose faster at 39.2% to ₹63.41 Cr and PAT accelerated to 42.3% at ₹44.13 Cr, with other income of ₹2.01 Cr remaining immaterial.

Segments

There is no segment table, but standalone growth outperformed the group: revenue grew 39.5% YoY and PAT 57.9% versus consolidated growth of 33.9% and 42.3%, implying subsidiaries or consolidation effects diluted the parent's growth contribution.

Key positives

• Consolidated revenue grew 33.9% YoY to ₹470.85 Cr, maintaining a high-growth trajectory.
• PAT grew 42.3% YoY to ₹44.13 Cr, ahead of revenue growth, while other income was only ₹2.01 Cr and earnings quality was classified as clean.
• Standalone revenue grew 39.5% YoY to ₹400.48 Cr and standalone PAT grew 57.9% to ₹32.06 Cr, materially faster than consolidated growth.
• EPS grew 42.3% YoY to ₹7.71, tracking PAT without a disclosed dilution-related divergence.

Key concerns

• Consolidated EBITDA grew 32.8% YoY to ₹75.13 Cr, slightly below revenue growth of 33.9%, so the 16% EBITDA margin did not expand on the disclosed figures.
• The filing does not disclose formulation/API/geography mix, volumes, pricing, R&D intensity or product-level drivers, limiting assessment of the quality and repeatability of growth.

View original filing

Research and educational content only. Not investment advice.